Boehringer Ingelheim GmbH

URI: https://gptkb.org/entity/Boehringer_Ingelheim_GmbH
GPTKB entity
Statements (44)
Predicate Object
gptkbp:instanceOf gptkb:biotechnology
gptkbp:annualR&DExpenditure €5 billion (2022)
gptkbp:awards gptkb:Top_Employer_Europe
Global Generics & Biosimilars Awards
gptkbp:businessModel family-owned
gptkbp:country gptkb:Germany
gptkbp:foundedIn 1885
gptkbp:founder gptkb:Albert_Boehringer
gptkbp:headquartersLocation Ingelheim am Rhein, Germany
https://www.w3.org/2000/01/rdf-schema#label Boehringer Ingelheim GmbH
gptkbp:industry pharmaceuticals
gptkbp:keyPerson gptkb:Hubertus_von_Baumbach
gptkbp:legalForm gptkb:company
gptkbp:logo Boehringer Ingelheim logo.svg
gptkbp:memberOf gptkb:European_Federation_of_Pharmaceutical_Industries_and_Associations
Verband Forschender Arzneimittelhersteller
gptkbp:memberState over 100
gptkbp:notableAcquisition Merial (animal health business from Sanofi)
gptkbp:notableProduct gptkb:Ofev
gptkb:Pradaxa
gptkb:Spiriva
gptkb:Jardiance
gptkb:Micardis
Trajenta
gptkbp:numberOfEmployees over 52,000
gptkbp:operatesIn global
gptkbp:parentCompany gptkb:Boehringer_Ingelheim_Group
gptkbp:products biopharmaceuticals
pharmaceutical drugs
animal health products
gptkbp:researchInterest immunology
oncology
cardiovascular diseases
metabolic diseases
central nervous system diseases
respiratory diseases
gptkbp:revenue €24.1 billion (2022)
gptkbp:slogan Value through Innovation
gptkbp:stockExchange not listed (private)
gptkbp:subsidiary gptkb:Boehringer_Ingelheim_Animal_Health
gptkbp:type gptkb:public_company
gptkbp:website https://www.boehringer-ingelheim.com/
gptkbp:bfsParent gptkb:Boehringer_Ingelheim_Group
gptkbp:bfsLayer 7